Wall Street Trims Their Price Targets but Remains Bullish on These 2 Ancillary Cannabis Stocks

: GRWG | GrowGeneration Corp. News, Ratings, and Charts

GRWG – With its rapid legalization across major states, demand for cannabis is expected to soar in the coming years amid new discoveries of its medicinal benefits. While Wall Street analysts have trimmed their price targets for ancillary cannabis stocks GrowGeneration (GRWG) and Innovative Industrial Properties (IIPR), they still expect them to rally by more than 80% in the coming months. So, we think it could be wise to add these stocks to one’s watchlist. Read on.

The cannabis industry is gaining popularity with increasing demand for cannabis’ medical and recreational use. Furthermore, with the rapid legalization of cannabis across major U.S. states, the industry is expected to grow in the next few years. Adding to the positives, the cannabis industry provides approximately 520,000 jobs in the United States–a number that is set to exceed 800,000 by 2026.

Fresh discoveries of medicinal benefits from cannabis should drive the industry’s growth further. According to Research and Markets, the global cannabis products market is projected to grow at a 23% CAGR to $80 billion in 2026. Therefore, fundamentally strong ancillary cannabis stocks should benefit.

While Wall Street analysts trimmed their price targets for ancillary cannabis stocks GrowGeneration Corp. (GRWG) and Innovative Industrial Properties, Inc. (IIPR), they still expect them to rally more than 80% in the coming months. So, it could be wise to add these stocks to one’s watchlist.

GrowGeneration Corp. (GRWG)

GRWG in Denver, Colo., and its subsidiaries own and operate retail hydroponic and organic gardening stores in the United States. It markets and distributes nutrients, growing media, advanced indoor and greenhouse lighting, environmental control systems, vertical benching, and accessories for hydroponic gardening and other indoor and outdoor growing products. On May 2, 2022, Stifel analyst W. Andrew Carter lowered GRWG’s price target to $8.50.

On March 1, 2022, Darren Lampert, GRWG’s Co-Founder and CEO, said, “We opened two greenfield locations in the Los Angeles metro area in 2021, and for next year, we are looking to open 15 to 20 locations across new and existing states.”  

GRWG’s sales came in at $90.58 million for the fourth quarter, ended Dec. 31, 2021, up 46.3% year-over-year. Its gross profit came in at $23.09 million, up 44.8% year-over-year. Furthermore, its net cash and cash equivalents provided by operating activities came in at $5.16 million for the period ended Dec. 31, 2021, compared to a $213,000 loss for the period ended Dec. 31, 2020.

For its fiscal year 2023, analysts expect GRWG’s revenue to be $512.89 million, representing a 20.3% year-over-year rise. The company’s EPS is expected to increase 366.7% to $0.28 in 2023. The stock has declined 36.9% in price over the past month to close yesterday’s trading session at $5.21. However, Wall Street analysts expect the stock to hit $9.63 in the near term, which indicates a potential 84.8% upside. 

Innovative Industrial Properties, Inc. (IIPR)

IIPR in San Diego, Calif., is a self-advised Maryland corporation focused on acquiring, owning, and managing specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. On May 6, 2022, Piper Sandler analyst Alexander Goldfarb lowered the price target on IIPR to $200.00.

On April 13, 2022, IIPR acquired a Maryland property that comprises approximately 84,000 square feet of industrial and greenhouse space. Paul Smithers, IIPR’s President and CEO said, “We are thrilled to introduce District Cannabis to our tenant roster, a company that has truly distinguished itself in Maryland for its premium product quality and focus on sustainable cultivation techniques.”

For the first quarter, ended March 31, 2022, IIPR’s total revenues came in at $64.50 million, up 50.4% year-over-year. Its net income came in at $35.05 million, up 35.2% year-over-year. Also, its EPS was  $1.32, up 25.7% year-over-year.

Analysts expect IIPR’s revenue to increase 40.8% year-over-year to $288.08 million in its fiscal year 2022. Its EPS is expected to increase 33.6% to $6.08 in 2022. The stock has declined  31% in price over the past month to close yesterday’s trading session at $130.38. However, Wall Street analysts expect the stock to hit $260.80 in the near term, which indicates a potential 100% upside.

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year

Top 10 Stocks for 2022

Bear Market Scare? Read Before Your Next Trade

7 SEVERELY Undervalued Stocks


GRWG shares were trading at $4.95 per share on Tuesday morning, down $0.26 (-4.99%). Year-to-date, GRWG has declined -62.07%, versus a -16.22% rise in the benchmark S&P 500 index during the same period.


About the Author: Riddhima Chakraborty


Riddhima is a financial journalist with a passion for analyzing financial instruments. With a master's degree in economics, she helps investors make informed investment decisions through her insightful commentaries. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
GRWGGet RatingGet RatingGet Rating
IIPRGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

How to Profit from the Growth Stock Crash?

The POWR Growth service has significatly outperformed the S&P 500 (SPY) despite a challenging environment for growth stocks. Now, there are subtle signs of improvement. Some of the best performing stocks were bought in the aftermath of market corrections and this time will be no different. Read on to find out how POWR Growth can help you profit for the rest of 2022…

:  |  News, Ratings, and Charts

5 High Growth Stocks to Buy Amid a Volatile Market

Concerns over aggressive interest rate hikes to fight the multi-decade high inflation and a looming recession have recently kept the stock market under pressure. However, growth stocks Taro Pharmaceutical (TARO), Superior Industries (SUP), Viavi Solutions (VIAV), CEVA (CEVA), and SMART Global Holdings (SGH) are well-positioned to rebound.

:  |  News, Ratings, and Charts

Bull vs. Bear Contingency Plans

The S&P 500 (SPY) has endured its 2nd trip down towards bear market territory before a bounce ensued. This last downturn is thanks to the ugly earnings from both WalMart and Target. This is indeed a precarious time and we have to contemplate the odds of bull vs. bear market and the related contingency plans we would enact in our portfolios. 40 year investment veteran, Steve Reitmeister, shares that and more in the commentary below…

:  |  News, Ratings, and Charts

4 Top-Rated Stocks Under $10 to Buy This Month

Though the major stock market indexes made a comeback yesterday following statements from the Biden administration hinting at the possibility of removing U.S tariffs on China, concerns over surging inflation and consequent monetary policy tightening are anticipated to keep the stock market under pressure in the near term. Therefore, we think it could be wise to bet on fundamentally sound low-priced stocks Assertio Holdings, Inc. (ASRT), Overseas Shipholding Group, Inc. (OSG), SunCoke Energy, Inc. (SXC), and Global Cord Blood Corporation (CO). These stocks are top-rated in our proprietary rating system.

:  |  News, Ratings, and Charts

Bull vs. Bear Contingency Plans

The S&P 500 (SPY) has endured its 2nd trip down towards bear market territory before a bounce ensued. This last downturn is thanks to the ugly earnings from both WalMart and Target. This is indeed a precarious time and we have to contemplate the odds of bull vs. bear market and the related contingency plans we would enact in our portfolios. 40 year investment veteran, Steve Reitmeister, shares that and more in the commentary below…

Read More Stories

More GrowGeneration Corp. (GRWG) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GRWG News